Imaging of sleep disorders in pre-Parkinsonian syndromes

被引:4
|
作者
Ota, Yoshiaki [1 ]
Kanel, Prabesh [2 ,3 ,4 ]
Bohnen, Nicolaas [2 ,3 ,4 ,5 ,6 ]
机构
[1] Univ Michigan, Div Neuroradiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiol, Div Nucl Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Morris K Udall Ctr Excellence Parkinsons Dis Res, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Parkinsons Fdn, Res Ctr Excellence, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[6] VAAAHS, GRECC Neurol Serv, Ann Arbor, MI USA
关键词
cardiac metaiodobenzylguanidine; diffusion tensor imaging; dopamine transporter imaging; single-photon emission computerized tomography; functional MRI; neuromelanin-sensitive MRI; Parkinson's disease; PET; prodromal clinical marker; rapid eye movement sleep disorder; PREDICTS EARLY TRANSITION; BEHAVIOR DISORDER; COERULEUS/SUBCOERULEUS COMPLEX; NEURODEGENERATIVE DISEASE; FUNCTIONAL CONNECTIVITY; DIFFERENTIAL-DIAGNOSIS; PRODROMAL DEMENTIA; SUBSTANTIA-NIGRA; GRAY-MATTER; BLOOD-FLOW;
D O I
10.1097/WCO.0000000000001084
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Neuroimaging has been advanced in the last years and enabled clinicians to evaluate sleep disorders, especially isolated rapid eye movement sleep disorder (iRBD), which can be seen in alpha-synucleinopathies. iRBD is the best prodromal clinical marker for phenoconversion to these neurodegenerative diseases. This review aims to provide an update on advanced neuroimaging biomarkers in iRBD. Recent findings Advanced structural MRI techniques, such as diffusion tensor imaging and functional MRI, neuromelanin-sensitive MRI, and scintigraphic neuroimaging such as cholinergic PET, dopamine transporter imaging - single-photon emission computerized tomography, perfusional single-photon emission computerized tomography, and cardiac metaiodobenzylguanidine can provide diagnostic and prognostic imaging biomarkers for iRBD, in isolation and more robustly when combined. New advanced neuroimaging can provide imaging biomarkers and aid in the appropriate clinical assessment and future therapeutic trials.
引用
收藏
页码:443 / 452
页数:10
相关论文
共 50 条
  • [1] Main sleep disorders in parkinsonian syndromes
    De Cock, V. Cochen
    CAHIERS DE L ANNEE GERONTOLOGIQUE, 2012, 4 (02): : 68 - 73
  • [2] Molecular Imaging of Parkinsonian Syndromes
    Intenzo, Charles
    Colarossi, Daly
    RADIOGRAPHICS, 2024, 44 (02)
  • [3] FUNCTIONAL IMAGING IN RELATION TO PARKINSONIAN SYNDROMES
    BROOKS, DJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 115 (01) : 1 - 17
  • [4] Structural and Functional Imaging in Parkinsonian Syndromes
    Broski, Stephen M.
    Hunt, Christopher H.
    Johnson, Geoffrey B.
    Morreale, Robert F.
    Lowe, Val J.
    Peller, Patrick J.
    RADIOGRAPHICS, 2014, 34 (05) : 1273 - 1292
  • [5] Characterization of gastrointestinal disorders in patients with parkinsonian syndromes
    Park, Hyeyoung
    Lee, Jee Young
    Shin, Cheol Min
    Kim, Jong-Min
    Kim, Tae Jeong
    Kim, Ji Won
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (05) : 455 - 460
  • [6] Disorders of the general metabolism in the parkinsonian postencephalitic syndromes
    Draganesco
    Kauffmann-Cosla
    Draganesco, L
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1927, 97 : 989 - 990
  • [7] Sleep phenotypes and proteinopathy in Parkinsonian disorders
    Briel, Nils
    Marti, Celine
    Werth, Esther
    Baumann, Christian
    Baumann-Vogel, Heide
    Schreiner, Simon
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [8] TSPO imaging in parkinsonian disorders
    Gerhard A.
    Clinical and Translational Imaging, 2016, 4 (3) : 183 - 190
  • [9] Structural imaging in the differential diagnosis of parkinsonian syndromes
    Schrag, A
    NERVENHEILKUNDE, 2000, 19 (09) : 479 - 481
  • [10] Gait and balance disorders in patients with atypical parkinsonian syndromes
    Welter, M. -L.
    Westby, G. W. M.
    Chastan, N.
    REVUE NEUROLOGIQUE, 2010, 166 (02) : 188 - 195